Is the increase in eltrombopag dose cause of myocardial infarction?

Is the increase in eltrombopag dose cause of myocardial infarction?

Bibliographic Details
Main Authors:	Edip Can Özgünoğlu, Nermin Bayar, Şakir Arslan, Muhammed Rıdvan Ersoysal, Rauf Avcı
Format:	Article
Language:	English
Published:	KARE Publishing 2021-07-01
Series:	Anatolian Journal of Cardiology
Online Access:	https://anatoljcardiol.com/jvi.aspx?un=AJC-45605&volume=25&issue=7

Similar Items

Six-year outcomes of carotid artery stenting performed with multidisciplinary management in a single center
by: Erkan Köklü, et al.
Published: (2021-06-01)

Acute Myocardial Infarction Due to Eltrombopag Therapy in a Patient with Immune Thrombocytopenic Purpura
by: Sena Sert, et al.
Published: (2017-03-01)

Asymptomatic Cerebral Emboli Following Carotid Artery Stenting: A Diffusion-Weighted MRI Study
by: Erkan Köklü, et al.
Published: (2022-12-01)

Unexpected cause of involuntary muscle movements: Reel syndrome
by: Görkem Kuş, et al.
Published: (2021-07-01)

Treatment of main coronary obstruction with renal stent implantation after transcatheter aortic valve implantation
by: Şakir Arslan, et al.
Published: (2021-08-01)

Visceral fat index: a novel predictor for coronary collateral circulation
by: Yasin Sahinturk, et al.
Published: (2020-03-01)

The association between apelin gene polymorphism and coronary artery disease in young patients with acute obstructive coronary syndrome
by: Ramazan Güven, et al.
Published: (2017-09-01)

Rapidly improving acute myocarditis after a scorpion sting
by: Nermin Bayar, et al.
Published: (2013-10-01)

Eltrombopag in Good’s Syndrome
by: Håvard Anton Kristiansen, et al.
Published: (2014-01-01)

Successful Management of Ibrutinib-Induced Thrombocytopenia with Eltrombopag in a Patient with Waldenström Macroglobulinemia
by: Abdulkadir Erçalışkan, et al.
Published: (2022-11-01)

The role of the presence of fragmented QRS in predicting disease severity in patients with pulmonary hypertension
by: Gorkem Kus, et al.
Published: (2022-12-01)

Transcatheter valve-in-valve implantation for sutureless bioprosthetic aortic paravalvular leak in the era of COVID-19
by: Şakir Arslan, et al.
Published: (2021-03-01)

Eltrombopag increases the hematopoietic supporting ability of mesenchymal stem/stromal cells
by: Sandra Muntión, et al.
Published: (2022-12-01)

Severe Refractory Immune Thrombocytopenia Successfully Treated with High-Dose Pulse Cyclophosphamide and Eltrombopag
by: Faiz Anwer, et al.
Published: (2015-01-01)

A rare combination of vascular anomalies: Hypoplastic aortic arch, coarctation of the aorta and poststenotic aneurysm
by: Nermin Bayar, et al.
Published: (2015-04-01)

Subarachnoid hemorrhage that electrocardiographically mimics acute coronary syndrome: a case report
by: Erkan Köklü, et al.
Published: (2015-12-01)

Transcatheter aortic valve implantation through the brachial artery
by: Şakir Arslan, et al.
Published: (2021-04-01)

Giant Coronary Artery Aneurysm Causing Acute Anterior Myocardial Infarction
by: Ahmet Yanık, et al.
Published: (2016-01-01)

Dose-dependent effects of atorvastatin on myocardial infarction
by: Barbarash O, et al.
Published: (2015-06-01)

Paraganglioma causing a myocardial infarction
by: Gerard DeMers, et al.
Published: (2012-01-01)

Eltrombopag for use in children with immune thrombocytopenia
by: Taylor Olmsted Kim, et al.
Published: (2018-02-01)

Eltrombopag, a potent stimulator of megakaryopoiesis
by: Hana Raslova, et al.
Published: (2016-12-01)

Exploring the Potential of Eltrombopag: Room for More?
by: Francesco Tarantini, et al.
Published: (2022-05-01)

Multiple thrombosis during eltrombopag therapy
by: Yutaka Shimazu, et al.
Published: (2021-05-01)

Low-Dose Eltrombopag in a Patient with Chronic Idiopathic Thrombocytopenic Purpura Post Sleeve Gastrectomy
by: Mohanad A. Ahmed, et al.
Published: (2020-06-01)

Assessment of the association between the personality traits of young patients with acute coronary syndrome and the severity of coronary artery disease
by: Nermin Bayar, et al.
Published: (2017-09-01)

EFFECT OF HIGH DOSES OF ATORVASTATIN IN ACUTE MYOCARDIAL INFARCTION
by: SH. A. Ubaydullaev
Published: (2019-06-01)

Could sST2 Predict Contrast-Induced Nephropathy in ST-Segment Elevation Myocardial Infarction?
by: Avcı A, et al.
Published: (2020-11-01)

Diabetes is associated with increased and persistent myocardial edema in infarct segment post acute myocardial infarction
by: Zia Mohammad I, et al.
Published: (2012-02-01)

Impact of Eltrombopag Therapy in Different Lines of Treatment on Response in Patients with Immune Thrombocytopenia
by: Abdülkadir Karışmaz, et al.
Published: (2024-08-01)

Refractory immune thrombocytopenia responding to combination therapy of eltrombopag and low-dose rituximab: a case series
by: Tan-Huy Chu, et al.
Published: (2024-11-01)

Therapeutic Doses of Eltrombopag do not Inhibit Hepatic BCRP in Healthy Volunteers: Intravenous Ceftriaxone as a Model
by: Daniel Valente Neves, et al.
Published: (2018-06-01)

PB2311: LOW-DOSE PREDNISON AND ELTROMBOPAG COMBINATION AS FRONTLINE TREATMENT IN NEWLY DIAGNOSED ITP PATIENTS
by: S.-Y. Liu, et al.
Published: (2022-06-01)

MYOCARDIAL INFARCTION IN YOUNG PATIENTS: CAUSES AND PROGNOSIS
by: E. V. Konstantinova, et al.
Published: (2017-07-01)

Myocardial Infarction as a Rare Cause of Otalgia
by: Riza Dundar, et al.
Published: (2014-01-01)

Aplastic Anemia Treated with Eltrombopag during Pregnancy
by: Yuri Suminaga, et al.
Published: (2022-01-01)

Adding eltrombopag to immunosuppression: the importance of predicting outcome
by: André Tichelli, et al.
Published: (2021-04-01)

Eltrombopag directly activates BAK and induces apoptosis
by: Meng Chen, et al.
Published: (2023-07-01)

Treatment of immune thrombocytopenic purpura: focus on eltrombopag
by: Lawrence Rice
Published: (2009-03-01)

Eltrombopag for the Treatment of Immune Thrombocytopenia: The Aegean Region of Turkey Experience
by: Füsun Özdemirkıran, et al.
Published: (2015-12-01)